Literature DB >> 22014139

The association of diabetes and dementia and possible implications for nondiabetic populations.

Ramit Ravona-Springer1, Michal Schnaider-Beeri.   

Abstract

Diabetes and prediabetic states have consistently been shown to be risk factors for cognitive decline, mild cognitive impairment and dementia. The importance of these findings is that diabetes and diabetes-related factors are modifiable, potentially permitting interventions aimed at postponing or preventing dementia. However, diabetes control cannot yet be implemented universally in diabetic subjects as a strategy for dementia prevention since the mechanisms by which diabetes impairs brain function and cognition are not fully understood. It is not clear which of the diabetes-related factors is crucial to this relationship. In addition, strict diabetic control has been demonstrated to carry risk for certain diabetic populations. The aim of the current article is to discuss current understanding of the relationships of diabetes and some of its characteristics with dementia, and suggest future questions to be answered.

Entities:  

Mesh:

Year:  2011        PMID: 22014139      PMCID: PMC3240939          DOI: 10.1586/ern.11.152

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  108 in total

1.  Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons.

Authors:  M Lesort; G V Johnson
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European Male Ageing Study.

Authors:  Jos Tournoy; David M Lee; Neil Pendleton; Terence W O'Neill; Daryl B O'Connor; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Carly M Moseley; Margus Punab; Alan J Silman; Dirk Vanderschueren; Frederick C W Wu; Steven Boonen
Journal:  Diabetes Metab Res Rev       Date:  2010-11       Impact factor: 4.876

3.  Insulin receptors are widely distributed in the central nervous system of the rat.

Authors:  J Havrankova; J Roth; M Brownstein
Journal:  Nature       Date:  1978-04-27       Impact factor: 49.962

4.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

Authors:  J Heitner; D Dickson
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

5.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

6.  Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.

Authors:  Jennifer Rodriguez-Rivera; Larry Denner; Kelly T Dineley
Journal:  Behav Brain Res       Date:  2010-08-13       Impact factor: 3.332

Review 7.  Hypoglycaemia and dementia in diabetic patients.

Authors:  B Bauduceau; J Doucet; L Bordier; C Garcia; O Dupuy; H Mayaudon
Journal:  Diabetes Metab       Date:  2010-10       Impact factor: 6.041

8.  Tau is hyperphosphorylated in the insulin-like growth factor-I null brain.

Authors:  Clara M Cheng; Victor Tseng; Jie Wang; Daniel Wang; Ludmila Matyakhina; Carolyn A Bondy
Journal:  Endocrinology       Date:  2005-08-25       Impact factor: 4.736

9.  Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

Authors:  D G Bruce; W A Davis; G P Casey; R M Clarnette; S G A Brown; I G Jacobs; O P Almeida; T M E Davis
Journal:  Diabetologia       Date:  2009-07-03       Impact factor: 10.122

10.  Impaired insulin secretion increases the risk of Alzheimer disease.

Authors:  E Rönnemaa; B Zethelius; J Sundelöf; J Sundström; M Degerman-Gunnarsson; C Berne; L Lannfelt; L Kilander
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

View more
  11 in total

1.  Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Andrew Levy; Derek Leroith; Michal S Beeri
Journal:  Diabetologia       Date:  2015-01-28       Impact factor: 10.122

2.  Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; James Schmeidler; Jeremy M Silverman; Mary Sano; Keren Koifmann; Rachel Preiss; Hadas Hoffman; Anthony Heymann; Michal Schnaider Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2013-08-08       Impact factor: 3.485

3.  MRI Metrics of Cerebral Endothelial Cell-Derived Exosomes for the Treatment of Cognitive Dysfunction Induced in Aging Rats Subjected to Type 2 Diabetes.

Authors:  Guangliang Ding; Lian Li; Li Zhang; Michael Chopp; Esmaeil Davoodi-Bojd; Qingjiang Li; Chao Li; Min Wei; Zhenggang Zhang; Quan Jiang
Journal:  Diabetes       Date:  2022-05-01       Impact factor: 9.337

4.  The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Jeremy M Silverman; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-05-14       Impact factor: 4.600

5.  Cognitive decline and dementia in the oldest-old.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Rambam Maimonides Med J       Date:  2012-10-31

6.  The effects of exercise training and caloric restriction on the cardiac oxytocin natriuretic peptide system in the diabetic mouse.

Authors:  Tom L Broderick; Marek Jankowski; Jolanta Gutkowska
Journal:  Diabetes Metab Syndr Obes       Date:  2017-01-11       Impact factor: 3.168

7.  Evaluation of Cognitive Impairment in Type 2 Diabetic Patients with Chronic Periodontitis: A Cross-sectional Study.

Authors:  Shikha Sharma; Sangeeta Umesh Nayak; Ashita Uppoor; Satish Rao; Keshava Pai; Srikant Natarajan
Journal:  J Int Soc Prev Community Dent       Date:  2021-01-30

8.  The Role of Molecular and Inflammatory Indicators in the Assessment of Cognitive Dysfunction in a Mouse Model of Diabetes.

Authors:  Iwona Piatkowska-Chmiel; Mariola Herbet; Monika Gawronska-Grzywacz; Marta Ostrowska-Lesko; Jaroslaw Dudka
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

9.  The influence of diabetes mellitus II on cognitive performance.

Authors:  Juliana Luchin Diniz Silva; Lucas Trindade Cantú Ribeiro; Nina Razzo Pereira Dos Santos; Vanessa Cristina Almeida de Sousa Beserra; Yara Dadalti Fragoso
Journal:  Dement Neuropsychol       Date:  2012 Apr-Jun

10.  Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia.

Authors:  Poonam Sharma; Prachi Kaushik; Swati Jain; Brij Mohan Sharma; Rajendra Awasthi; Giriraj Thirupathirao Kulkarni; Bhupesh Sharma
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-08-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.